NO964905L - Substituerte benzendikarboksylsyre-diguanidider, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen - Google Patents
Substituerte benzendikarboksylsyre-diguanidider, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsenInfo
- Publication number
- NO964905L NO964905L NO964905A NO964905A NO964905L NO 964905 L NO964905 L NO 964905L NO 964905 A NO964905 A NO 964905A NO 964905 A NO964905 A NO 964905A NO 964905 L NO964905 L NO 964905L
- Authority
- NO
- Norway
- Prior art keywords
- drug
- atoms
- alkyl
- diagnostic
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 2
- 229940079593 drug Drugs 0.000 title 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N benzene-dicarboxylic acid Natural products OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 title 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical class OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 title 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 230000006378 damage Effects 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000050381 Na+/H+ exchanger Human genes 0.000 abstract 1
- 108091006672 Sodium–hydrogen antiporter Proteins 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 230000003293 cardioprotective effect Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Det er beskrevet benzendlkarboksylsyre-diguanidider med formel (I) hvor en av restene R(l), R(2). R(3) og R(4) betyr -C0-N-C(NH2)2; og de andre restene R(l), R(2), R(3) og R(4) kan ha forskjellige betydninger og f.eks. kan R(l) bety hydrogen eller alkyl med 1, 2, 3 eller 4 C-atomer, R(2) og R(4) kan uavhengig av hverandre f.eks. bety hydrogen, OH, CF3, alkyl med 1, 2, 3 eller 4 C-atomer, R(3) kan f.eks. bety hydrogen eller -OH, R(5) kan f.eks. bety alkyl med 1, 2, 3 eller 4 C-atomer, F, Cl eller CF3. Disse forbindelsene er verdifulle antlarytmlske legemidler med kardlobeskyttende komponenter, også for forebyggelse av ischemisk induserte skader, spesielt ved utløsningen av ischemisk induserte hjertearytmier. De anvendes på grunn av inhiberingen av den cellulære Na+/H+-utveksler-n)ekanisroen for behandling av akutte og kroniske, ved ischemi utløste skader. Videre utmerket de seg ved sterkt inhiberende virkning på proliferasjonen av celler. De er egnede for å forebygge genesen ved høyt blodtrykk.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19543194A DE19543194A1 (de) | 1995-11-20 | 1995-11-20 | Substituierte Benzoldicarbonsäure-diguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE1996124064 DE19624064A1 (de) | 1996-06-17 | 1996-06-17 | Substituierte Benzoldicarbonsäure-diguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO964905D0 NO964905D0 (no) | 1996-11-19 |
| NO964905L true NO964905L (no) | 1997-05-21 |
Family
ID=26020502
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO964905A NO964905L (no) | 1995-11-20 | 1996-11-19 | Substituerte benzendikarboksylsyre-diguanidider, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen |
| NO964903A NO964903D0 (no) | 1995-11-20 | 1996-11-19 | Substituerte benzendikarboksylsyre-diguanidid, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO964903A NO964903D0 (no) | 1995-11-20 | 1996-11-19 | Substituerte benzendikarboksylsyre-diguanidid, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0774458A1 (no) |
| JP (1) | JPH09169719A (no) |
| KR (1) | KR980002018A (no) |
| AR (1) | AR004331A1 (no) |
| AU (1) | AU703352B2 (no) |
| BR (1) | BR9605617A (no) |
| CA (1) | CA2190693A1 (no) |
| CZ (1) | CZ338296A3 (no) |
| HR (1) | HRP960547A2 (no) |
| HU (1) | HUP9603201A3 (no) |
| IL (1) | IL119637A0 (no) |
| MX (1) | MX9605674A (no) |
| NO (2) | NO964905L (no) |
| NZ (1) | NZ299772A (no) |
| PL (1) | PL316438A1 (no) |
| SK (1) | SK148796A3 (no) |
| TR (1) | TR199600916A2 (no) |
| TW (1) | TW353657B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19819548A1 (de) | 1998-04-30 | 1999-11-04 | Merck Patent Gmbh | Biphenylderivate |
| DE10044732A1 (de) * | 2000-09-09 | 2002-03-21 | Mahle Ventiltrieb Gmbh | Rollenstößel für einen Verbrennungsmotor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2089600T3 (es) * | 1992-02-15 | 1996-10-01 | Hoechst Ag | Benzoilguanidina sustituida en 3,5, con efecto antiarritmico y efecto inhibidor de la proliferacion de celulas. |
| IL109570A0 (en) | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| IL114670A0 (en) * | 1994-08-05 | 1995-11-27 | Fujisawa Pharmaceutical Co | Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
-
1996
- 1996-10-08 PL PL96316438A patent/PL316438A1/xx unknown
- 1996-11-07 EP EP96117822A patent/EP0774458A1/de not_active Withdrawn
- 1996-11-18 TR TR96/00916A patent/TR199600916A2/xx unknown
- 1996-11-18 AU AU71804/96A patent/AU703352B2/en not_active Ceased
- 1996-11-18 IL IL11963796A patent/IL119637A0/xx unknown
- 1996-11-18 SK SK1487-96A patent/SK148796A3/sk unknown
- 1996-11-18 CZ CZ963382A patent/CZ338296A3/cs unknown
- 1996-11-18 AR ARP960105230A patent/AR004331A1/es unknown
- 1996-11-18 NZ NZ299772A patent/NZ299772A/xx unknown
- 1996-11-18 TW TW085114093A patent/TW353657B/zh active
- 1996-11-19 MX MX9605674A patent/MX9605674A/es unknown
- 1996-11-19 HU HU9603201A patent/HUP9603201A3/hu unknown
- 1996-11-19 HR HR19624064.6A patent/HRP960547A2/hr not_active Application Discontinuation
- 1996-11-19 KR KR1019960055375A patent/KR980002018A/ko not_active Withdrawn
- 1996-11-19 NO NO964905A patent/NO964905L/no unknown
- 1996-11-19 NO NO964903A patent/NO964903D0/no unknown
- 1996-11-19 BR BR9605617A patent/BR9605617A/pt unknown
- 1996-11-19 CA CA002190693A patent/CA2190693A1/en not_active Abandoned
- 1996-11-19 JP JP8307831A patent/JPH09169719A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HU9603201D0 (en) | 1997-01-28 |
| PL316438A1 (en) | 1997-05-26 |
| NO964905D0 (no) | 1996-11-19 |
| HUP9603201A3 (en) | 1997-11-28 |
| EP0774458A1 (de) | 1997-05-21 |
| AU703352B2 (en) | 1999-03-25 |
| NZ299772A (en) | 1998-12-23 |
| TW353657B (en) | 1999-03-01 |
| KR980002018A (ko) | 1998-03-30 |
| CA2190693A1 (en) | 1997-05-21 |
| TR199600916A2 (tr) | 1997-06-21 |
| AU7180496A (en) | 1997-05-29 |
| JPH09169719A (ja) | 1997-06-30 |
| IL119637A0 (en) | 1997-02-18 |
| AR004331A1 (es) | 1998-11-04 |
| BR9605617A (pt) | 1998-08-18 |
| NO964903D0 (no) | 1996-11-19 |
| CZ338296A3 (cs) | 1998-05-13 |
| HRP960547A2 (en) | 1998-02-28 |
| SK148796A3 (en) | 1997-10-08 |
| HUP9603201A2 (en) | 1997-05-28 |
| MX9605674A (es) | 1997-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9916732A (pt) | Derivados de ácido malÈnico, processo para a sua preparação, seu uso e composições farmacêuticas contendo-os (inibição da atividade do fator xa) | |
| NO934501L (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
| RU94044488A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования симптомов пременструального синдрома/ дисфории, связанной с поздней лютеальной фазой | |
| RU94036758A (ru) | Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома | |
| RU94036772A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза | |
| NO930511D0 (no) | Orto-substituerte benzoylguanidiner, fremgangsmaater for fremstillling av dem, deres anvendelse som diagnostikum saavel som medikamenter som inneholder dem | |
| BR0108694A (pt) | Derivados de ácido malÈnico, processo para preparação dos mesmos, uso dos mesmos como inibidor de atividade do fator xa e composições farmacêuticas que contêm os mesmos | |
| ES2109545T3 (es) | Benzoilguanidina sustituida, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico asi como el medicamento que la contiene. | |
| NO983435L (no) | Aspartylproteaseinhibitorer | |
| RU94037246A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования разрушения хряща | |
| BR0206791A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto | |
| BR0016678A (pt) | Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto | |
| CA2182062A1 (en) | Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them | |
| NO943210L (no) | Laktolderivater, deres fremstilling og anvendelse | |
| NO964905L (no) | Substituerte benzendikarboksylsyre-diguanidider, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| HU9200335D0 (en) | Medical products with human interleukin-2 content | |
| NO944699L (no) | Aminosubstituerte benzensulfornylurinstoffer og -tiourinstoffer, fremgangsmåte for deres fremstilling og deres anvendelse som farmasöytika | |
| NO940844L (no) | Farmasöytisk aktive hydroksykarboksylsyrederivater | |
| MX9704094A (es) | Benzoil-guanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
| NO305655B1 (no) | Antiarytmiske og kardiobeskyttende substituerte indenoylguanidiner, deres anvendelse for fremstilling av legemidler, samt legemiddel inneholdende disse | |
| HUP0102576A1 (hu) | Bifenil-szulfonil-cián-amidok, eljárás a vegyületek előállítására és gyógyszerként történő felhasználása | |
| MY117304A (en) | Ortho-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic, agent and a medicament comprising them. | |
| NO950665L (no) | Nye polyjoderte forbindelser, fremgangsmåte for deres fremstilling og kontrastmidler inneholdende disse | |
| NO972406L (no) | Bis-orto-substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| MX9605538A (es) | Benzoil-guanidinas sustituidas con sulfonilamino, procedimiento para su preparacion, su empleo como medicamento o para diagnostico, asi como el medicamento que las contiene. |